CBIO vs MPLT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

CBIO

41.2
AI Score
VS
MPLT Wins

MPLT

48.8
AI Score

Investment Advisor Scores

CBIO

41score
Recommendation
HOLD

MPLT

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO MPLT Winner
Net Income 153,942 -120.86M CBIO
Operating Income -152.63M -128.05M MPLT
ROE 0.1% -34.7% CBIO
ROA 0.1% -32.8% CBIO
Total Assets 240.29M 368.35M MPLT
Cash 213.19M 71.63M CBIO
Current Ratio 6.56 16.52 MPLT
Free Cash Flow -72.45M -96.09M CBIO

Relative Price Performance (Last 90 Days)

CBIO 1M: -22.8% · 3M: -15.6% MPLT 1M: -24.8% · 3M: -72.0%

Current Technical Phase

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.6 · Price: $14.32

MPLT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -44.3%), weak momentum, RSI 28

RSI (14): 28.4 · Price: $9.82

Fundamentals Snapshot

Metric CBIO MPLT
Market Cap — —
Forward P/E -5.4 -3.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 1.0% —
Operating Margin -14.3% 0.0%
EPS -0.14 -18.88
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MPLT is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.